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Background: To evaluate intraoperative and postoperative cytokines in patients who underwent robotic prostatectomy (RP) at a
pressure of 12 or 15mmHg, and the risk of postoperative ileus.
Materials andmethods:We presented the first series evaluating intraoperative and postoperative cytokines in patients undergoing
RP at a pressure of 12 or 15mmHg by a single surgeon. Changes in cytokine concentrations were shown to correlate with surgical
outcomes and pathological states. The study investigated the changes in cytokine concentrations (interferon-g, tumor necrosis
factor-a, interleukin-1b [IL-1b], IL-2, IL-4, IL-6, IL-12, and IL-17) at different pneumoperitoneum pressures and their potential role in
the development of postoperative ileus.
Results: The data on 10 consecutive patients confirmed that a lower pneumoperitoneum pressure was associated with lower
cytokine levels and a lower risk of ileus. There were increased levels of postoperative interferon-g, tumor necrosis factor-a, IL-12p70,
IL-1b, IL-2, IL-4, and IL-17a at 15mmHg when compared to 12mmHg.
Conclusions: The data indicated that lower pressure RP reduced intra-/postoperative cytokine levels confirming our hypothesis.
Larger patient numbers are required to further validate this but the implications of this data will benefit not only urological patients but
also other speciality patients undergoing minimally invasive surgery.
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Postoperative ileus (POI) is a complication defined as a temporary
nonmechanical inhibition of bowl motility preventing oral intake
and presenting with decreased passage of flatus/stool and absence
of bowel sounds.[1] This is a common complication affecting
between 5% and 25% of patients undergoing trans-abdominal
surgery, and it results in patient discomfort, prolonged admis-
sion, and delayed recovery.[2]
In urology, minimally invasive robotically assisted laparo-
scopic surgery has resulted in a dramatic reduction in
postoperative complications, length of stay, transfusion rates,
and an increase in better oncological outcomes. This has resulted
in 74% of all prostatectomies performed in the UK being
robotically assisted, a figure which was anticipated to reach 80%
by 2020.[3,4] Despite the improvement in many areas of∗
Corresponding Author: Nikhil Vasdev, Department of Urology, Lister Hospital,
Stevenage, SG1 4AB, UK. E-mail address: nikhilvasdev@doctors.org.uk (N.
Vasdev).
Current Urology, (2021) 15, 91-94
Received April 1, 2020; Accepted June 2, 2020.
http://dx.doi.org/10.1097/CU9.0000000000000027
Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. This is
an open access article distributed under the terms of the Creative Commons
Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it
is permissible to download and share the work provided it is properly cited. The
work cannot be changed in any way or used commercially without permission
from the journal.
91postoperative recovery, robotic surgery still has POI as one of
its main complications.[2]
Operative factors such as a steep Trendelenburg position
(which is required to reflect the bowel away from the pelvic
organs), occasional peritoneal adhesiolysis, and high intra-
abdominal pressures with CO2 insufflation of 15–20mmHg that
is necessary for the creation of the pneumoperitoneum predis-
poses robotic urological surgery patients to POI. Rohloff et al.
published a retrospective study in October 2019, which showed
that POI rates could be significantly reduced by lowering
intraoperative pneumoperitoneum from 15 to 12mmHg.[5] This
finding supports the pathophysiology proposed by Luo et al. that
intraabdominal pneumoperitoneum pressure could lead to an
ischemia-reperfusion injury of the bowel due to changes in
splanchnic blood flow during insufflation/desufflation.[6] This
pathophysiology could indicate a potential for a predictive
biomarker should a suitable measurable factor be identified. An
animal study investigating bowel manipulation found a signifi-
cant increase in activated macrophages that also resulted in
reduced gut motility.[7] The inflammatory response triggered by
these macrophages is cytokine mediated with tumor necrosis
factor-a (TNF-a), interferon-6 (IL-6), C-C motif chemokine
ligand 2, IL-1b, and IL-10 having been previously highlight-
ed.[8,9]
We hypothesized that cytokine levels, whether individual or in
combination, may indicate a risk or predictive value of POI. A
prospective pilot study was proposed to investigate the changes in
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Mean age, years 65±6.3 62±5.2
Body mass index, kg/m2 25.9±3.6 30.2±3.2
Prostate specific antigen, mg/L 10.2±2.8 8.1±2.8
Operative time, min 170±14 165±52. Methods
Local and national ethical approval for the described protocol
was granted by the Health Resource Authority (NHS England).
Ten patients undergoing RP were prospectively enrolled in the
study. The positioning, preoperative care, and surgical technique
were identical in all patients. Five patients underwent RP at a
pneumoperitoneum pressure of 12mmHg and the other 5 at a
pressure of 15mmHg. A single surgeon at a single institute (NV)
performed all the procedures using a standardized transperito-
neal robotic assisted laparoscopic technique with a Da Vinci
Si®robotic system. Pneumoperitoneum was maintained through-
out the procedure by using the AirSeal® intelligent flow system.
All patients received a standardized general anesthetic consisting
of fentanyl 100mg, midazolam 2mg, and propofol induction and
intubation facilitated by atracurium. In addition, paracetamol 1
g, ketorolac 30mg, ondansetron 4mg, and dexamethasone 6.6
mg were given. Anesthesia was maintained with oxygen, air, and
desflurane through a circular system and positive pressure
ventilation. Muscle relaxation was maintained with atracurium
infusion. The caudal block administered contained 40mL 0.25%
bupivacaine, 150mg clonidine, and 100mg fentanyl. Bupiva-
caine 0.5% 20mL was infiltrated into the skin wounds at the end
of the operation. Regular paracetamol was prescribed postoper-
atively and ketorolac 30mg im, oramorph 20mg, and cyclizine
were available on an as required basis. As per ERAS enhanced
recovery recommendations, patients were encouraged to mobi-
lize immediately after surgery, and clear fluids progressing to a
soft diet was advised on day one as tolerated. Intravenous fluids
are not routinely prescribed postoperatively as oral intake was
encouraged. Patients were discharged within 28days and
subcutaneous low molecular weight heparin was stopped and
the urethral catheter was removed at day 14 postoperatively.
Five blood samples were taken for cytokine analysis for each
patient in the peri- and postoperative period as per the following
protocol:
Sample A (preinduction): Taken prior to anesthesia, and served as
an initial patient specific baseline and as second preoperative
baseline prior to insufflation to account for any post procedural
changes that may occur.
Sample B: Postinduction and preinsufflation.
Sample C: Taken immediately postoperatively and postextuba-
tion.
Sample D: Taken 2hours postoperatively.
Sample E: Taken 14days postoperatively at the time of trial
without catheter.
Venous blood samples were collected in EDTA vials and were
kept at 2–8°C while being handled and were immediately
processed. Samples underwent centrifugation in a refrigerated
centrifuge at 1000g at 4°C for 15 minutes. The plasma was
aliquoted and stored at 80°C until analysis.
The following 9 cytokines were included for assay analysis: IL-
6, IL-10, interferon-g (IFN-g), IL-12p70, IL-1b, IL-2, IL-4, TNF-
a, and IL-17a. Analysis of plasma samples was performed as per
manufacturer’s instructions using a High Sensitivity 9-Plex
Human ProcartaPlexTM Panel kit (LCP0010) from Thermo
Fisher Scientific. Cytokine levels were measured on a Luminex
MAGPIX (Luminex Corp.), and analysed using theMILLIPLEX
®
Analyst software version 5.1 (Merck Millipore).92The raw data was measured as mean fluorescent intensity and
the concentration of each cytokine in each sample was calculated
using a 5-parameter logistic fit curve generated for each analyte
from standards. Concentrations of cytokines were compared for
differing pneumoperitoneum pressures.
Secondary data were collected on age, body mass index, renal
function, intraoperative blood loss, operative/console time, on-
table complications, ileus rates, postoperative complications, and
length of stay. POI was defined as the inability to tolerate oral
intake with decreased passage of flatus/stool and absence of
bowel sounds with or without confirmatory radiological imaging
in the absence of mechanical obstruction in the 2-week period
following RP.3. Results
3.1. Patient demographics
Ten patients were recruited to the study and successfully
underwent RP, 5 at a pneumoperitoneum pressure of 12mm
Hg and 5 at a pressure of 15mmHg as per protocol. As shown in
Table 1, the mean age was 65 and 62years, respectively, and the
average body mass index was 25.9 and 30.2kg/m2, respectively.
Preoperative prostate specific antigen levels were similar, with
means of 10.2mg/L for the 12mmHg group and 8.1mg/L for the
15mmHg group. All preoperative Gleason scores were between
3+3=6 and 4+3=7.
3.2. Primary outcomes
There were 2 episodes of POI, both of which occurred in patients
in the 15mmHg group resulting in a POI rate of 40% (2/5) for
this group but due to the small group sizes this was not significant
(p=0.2235) and cytokine levels specifically for the POI patients
were also not significant.
Samples A and B, the samples taken preinduction and
preinsufflation, were used to create baseline cytokine levels for
each group, to which we could compare the postoperative levels.
Table 2 shows the results of plasma concentrations for each
cytokine for both 12 and 15mmHg groups.
Analysis of cytokines in plasma samples collected preinduction
(samples A and B), immediately postoperatively and postextu-
bation (sample C), 2hours postoperatively (sample D), and 14
days postoperative (sample E) revealed the trends shown in
Table 2. There were large sample variations within groups
because of the small numbers used in this pilot study. As a result,
there were not major statistical differences between conditions.
Despite this, there were evident trends between samples collected
from the 12mmHg group compared to the 15mmHg group. For
instance, all cytokines, with the exception of IL-6 and IL-10, were
detected at much higher levels in the 15mmHg group. IL-10 was




Pneumoperitoneum pressure 12mmHg Pneumoperitoneum pressure 15mmHg
Cytokine Baseline B Sample C Sample D Sample E Baseline B Sample C Sample D Sample E
IFN-g 23.2±7.2 20.9±6.4 17.8±6.3 12.3±7.8 42.8±24.9 30.8±18.3 30.7±18.9 14.1±2.2
TNF-a 5.6±2.8 4.1±1.90 4.6±1.8 2.2±0.8 7.9±3.0 6.2±2.1 5.2±2.1 5.5±0.3
IL-12p70 6.0±3.2 4.3±2.3 4.1±1.5 2.8±0.9 9.7±4.4 6.6±2.2 5.2±1.9 5.7±0.8
IL-1b 3.4±1.0 3.1±0.9 2.1±0.9 2.1±1.1 7.9±3.8 5.6±3.0 5.1±3.1 3.0±0.3
IL-2 3.0±1.4 2.9±1.7 2.9±1.3 1.4±0.4 5.0±1.7 3.8±1.1 2.7±1. 3.9±0.3
IL-4 8.8±3.9 7.4±2.7 7.4±2.3 4.9±1.6 17.6±8.7 16.0±7.2 13.1±6.6 10.2±1.4
IL-6 36.6±13.0 110.4±38.4 106.5±36.1 27.1±7.7 58.4±31.7 84.0±28.3 106.5±37.7 18.5±5.2
IL-10 2.2±0.5 16.8±9.1 27.8±10.2 3.1±1.5 2.2±0.3 10.92±2.90 9.20±3.28 2.34±0.19
IL-17a 2.02±0.71 1.75±0.68 1.68±0.51 1.18±0.26 3.12±0.9 2.2±0.5 1.8±0.5 2.6±0.2
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C), and also 2hours postoperative (sample D). IL-6 also appeared
enhanced following these procedures but the levels in samples D
did not differ between the 12 and 15mmHg groups. What is
interesting and worth noting from our pilot data is the fact that
IFN-g, TNF-a, IL-12p70, IL-1b, IL-2, IL-4, and IL-17a remained
elevated in the 15mmHg group even 14days postprocedure at
the time of trial without a catheter.
3.3. Secondary outcomes
Most of the secondary outcomes were unaffected by the change in
pneumoperitoneum pressures with length of stay, operative/
console time, and postoperative Hb and renal function being
found to be not significantly different between the two groups
(p>0.05). There was a clinically significant increase in
intraoperative blood loss in the 12mmHg group compared to
the 15mmHg group (p<0.05). With the exception of the 2
episodes of POI, no postoperative complications were recorded in
either group (Table 3).4. Discussion
While our data correlates with the findings of Rohloff et al.[5] that
higher pneumoperitoneum pressures increases POI risk, with
40% of patients with higher insufflation pressures developing
POI, unfortunately, due to the small sample size no statistical
significance was reached in our study.
Luo et al. theorised that prolonged pneumoperitoneum
pressure resulted in decreased splanchnic blood flow and proved










Intraoperative blood loss, mL 93±69 56±9 <0.05
Length of stay, days 1.6±0.5 2±0 0.910
Operative time, min 170±14 165±5 0.578
Console time, min 143±19 140±14 0.553
Postoperative Hb, g/L 117.2±6.4 120.4±4.3 0.941
Postoperative creatinine, mmol/L 87.6±17.3 87.2±4.4 0.076
93hypoperfusion-reperfusion injury.[6] In their study, Malondial-
dehyde was used to assess levels of oxidative stress along with
intramucosal pH, while incredibly useful to investigate the
pathophysiology. However, this method required arterial blood
samples and invasive procedures (NG tube), and thus was not
ideal for a monitoring/screening test.
Manymarkers of oxidative stress have been proposed, including
but not limited to, gastric intramucosal pH, histological tissue
analysis, malondialdehyde, F2-isoprostanes and cytokines.[10]
Our pilot study investigated 9 frequently studied pro-
inflammatory, anti-inflammatory, and regulatory cytokines,
and assessed the changes in concentration in relation to different
insufflation pressures. There were increased levels of postopera-
tive IFN-g, TNF-a, IL-12p70, IL-1b, IL-2, IL-4, and IL-17a at 15
mmHg when compared to 12mmHg. These findings are
comparable to the work performed by Zhu et al.[11] which
found elevated postoperative levels of abdominal exudates TNF-
a, IL-1b, and IL-6 following laparoscopic colorectal surgery and
showed that these changes were associated with poor surgical
outcome, principally the development of POI. In their study, it
was shown that 88%–100% of the patients that developed POI
had elevated levels of TNF-a, IL-1b, or IL-6 at day 5 compared to
elevated levels in only 14%–16% of the patients that did not
develop POI.
We also investigated the ratio between IL-6, a pro-inflamma-
tory mediator which regulates systemic inflammatory responses,
and IL-10, an anti-inflammatory cytokine involved in the
negative feedback loops of other cytokine production path-
ways.[12] Plasma levels of IL-6 were raised in both groups but in
the higher pressure group these levels were reduced at a much
slower rate. The IL-10 concentration decreased in the 15mmHg
group, potentially indicating a prolonged injury and larger
inflammatory response.
This ratio between IL-6 and IL-10 has previously been linked to
systemic inflammatory response related mortality and higher
injury severity scores.[13] This ratio was useful in accurately
differentiating between the 12 and 15mmHg groups in our
studies. Unfortunately, due to the small sample size and even
smaller number of cases of POI, there was not sufficient data to
give clinical relevance.5. Conclusion
Current research into specific cytokine pathophysiology has not
yet reached the level of detail required to be used as a biomarker.
Hampson et al.  Volume 15  Issue 2  2021 www.currurol.orgThe majority of the published literature focused on research into
the initial stages of trying to identify a correlation between
pathological states and variations in cytokine concentrations,
whereas studies establishing diagnostic cut-offs were in the
minority. Research into baseline cytokine concentrations in
pathological states is rarely published and limits potential future
study designs. It is clear that there is huge potential for cytokine
research to be used as prognostic and diagnostic biomarkers for
many conditions and postoperative complications but further
research, especially with a focus on diagnostic ranges and
significant cut-off levels is the key to unlocking this potential.
This study was built on existing work such as Rohloff et al.[5]
and Zhu et al.,[11] and confirmed that plasma concentrations of
cytokines IFN-g, TNF-a, IL-12p70, IL-1b, IL-2, IL-4 and IL-17a,
and IL-17a are increased in higher pressures of pneumo-
peritoneum insufflation. Further research is required to identify
a statistically significant cut-off value that will allow cytokine
profiles to be used as predictor biomarkers of POI. This requires
larger sample sizes and therefore higher number of POI cases, and
a larger variability of patients.Acknowledgments
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